Skip to main content
Premium Trial:

Request an Annual Quote

Promega, SABiosciences Partner on Pathway Assay Technologies

NEW YORK (GenomeWeb News) – Promega today said that it and SABiosciences will combine their research tools for interrogating specific cellular pathways via transcription factor reporters.

Under the deal, Promega's recombinant firefly luciferase luc2 gene and a humanized Renilla luciferase (hRluc) gene will serve as one key reporter system for SABiosciences' Cignal pathway reporter assays.

Dave Martz, VP of sales and marketing for SABiosciences, said in a statement that Promega's luciferase reporters "provide the necessary levels of sensitivity for studying the effects of drugs or genetic perturbations on many interesting and biologically relevant cell types."

Terms of the alliance were not disclosed.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.